[ad_1] OSLO, Norway, Oct. 28, 2025 /PRNewswire/ — In the third quarter 2025, Navamedic ASA (OSE: NAVA), a Nordic pharma company and trusted supplier of high-quality prescription, consumer health, and hospital products to hospitals and pharmacies, […]
Tag: Navamedic ASA
Continued growth in a year with investments in new growth initiatives
[ad_1] OSLO, Norway, Feb. 12, 2025 /PRNewswire/ — For the full year 2024, Navamedic ASA (OSE: NAVA), a Nordic pharma company and reliable provider of high-quality products to hospitals and pharmacies, delivered revenues of NOK 531.3, […]
Stable growth continues and is supported by a new licensing and supply agreement
[ad_1] OSLO, Norway, Aug. 16, 2024 /PRNewswire/ — In first half of 2024, Navamedic ASA (OSE: NAVA), a Nordic pharma company and reliable provider of high-quality products to hospitals and pharmacies, delivered revenues of NOK 277.2 […]
